Not Yet RecruitingNCT07833761

ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder

This study is not yet recruiting. It focuses on personality disorders and currently lists study information in the United States.

Personality disorders, Suicidality, ...DrugFrom 25 Years to 65 Years

The study in practice

Understand this study

Who could participate?

Listed age limits: 25 years to 65 years.

Listed locations: Minneapolis, United States · Saint Louis Park, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: December 1, 2026

Recruitment status: Not Yet Recruiting
Enrollment listed in the registry: 18
Sponsor: University of Minnesota
Sponsor type: University
Study type: Drug
Intervention type: Psychotherapy / behavioral intervention, Medication / drug
Study phase: Phase 1
Locations: United States
Age range: From 25 Years to 65 Years
Official registry ID: NCT07833761
Official title: ADEPT: Augmenting DBT Effectiveness With Psilocybin-Assisted Therapy

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Study ID: NCT07833761. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Not yet recruiting

Minneapolis · Saint Louis Park

Registry details

Registry conditions (original wording)

Borderline Personality Disorder; Borderline Personality Pathology; Depressive Symptoms; Emotion Dysregulation; Suicidal Ideation

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Minnesota, a university.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

Listed age limits: 25 years to 65 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me